Evidence map›Paper›PMID 41410897›Full record

ReviewCell biochemistry and biophysics2026

Elucidating the Structure and Activation Mechanisms of GPCRs Using Modern Computational and AI Tools.

Abdullahi Ibrahim Uba

Abstract readReview
PubMed Publisher
In one paragraph

Review in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Abdullahi Ibrahim UbaDepartment of Molecular Biology and Genetics, Istanbul AREL University, Istanbul, 34537, Türkiye. abdullahi.iu3@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) form the largest family of membrane-spanning signaling proteins that allow cells to detect and respond to a wide range of extracellular signals. Although they are key drug targets in over a third of FDA-approved medicines, our understanding of the allosteric mechanisms that control GPCR activation and signal transduction remains limited. Recent advances in high-resolution structural techniques, such as cryo-electron microscopy (cryo-EM) and X-ray crystallography, combined with innovative molecular dynamics (MD) simulations and AI-driven structural prediction models, have significantly expanded our knowledge of GPCR conformational states. This review explores the structural basis of GPCR activation, highlighting conserved activation motifs like D(E)RY, NPxxY, and CWxP, as well as changes in transmembrane helices, interaction sites for G proteins and arrestins, and the roles of membrane lipids and allosteric modulators. It discusses the increasing use of machine learning (ML) and deep learning (DL) in structure prediction, ligand bias analysis, free-energy landscape mapping, and conformational classification. Ultimately, the review underscores how combining AI tools with traditional MD and enhanced sampling techniques can deepen our understanding of GPCR activation pathways, aiding rational drug development.

Indexed as

Receptors, G-Protein-CoupledCrystallography, X-RayDeep LearningHumansLigandsMachine LearningMolecular Dynamics SimulationProtein ConformationLigandsReceptors, G-Protein-CoupledActivation mechanismsAI-powered toolsDeep learningGPCRsMachine learningMD simulation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.